StockClub
ASCLFAscletis Pharma Inc.$ --
Ascletis Pharma Inc.

Ascletis Pharma Inc.

ASCLF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 06/30/2025FY2025 Q2
Revenue
1M CNY
YoY +Infinity%
Operating Income
-190M CNY
YoY -9.4%
Net Income
-88M CNY
YoY +32.5%
EPS
-0.09CNY
YoY +28.7%

Revenue

CNY1.1M
FY2021 Q4CNY76.9M
CNY76.9M
Q4
FY2022 Q2CNY38.2M
CNY38.2M
Q2
FY2022 Q4CNY54.1M
CNY54.1M
Q4
FY2023 Q2CNY46.5M
CNY46.5M
Q2
FY2023 Q4CNY56.6M
CNY56.6M
Q4
FY2024 Q2CNY0
CNY0
Q2
FY2024 Q4CNY1.3M
CNY1.3M
Q4
FY2025 Q2CNY1.1M
CNY1.1M
Q2
Actual
+CNY1.1M (-)

Net Income

CNY-88M
FY2021 Q4CNY-199M
CNY-199M
Q4
FY2022 Q2CNY-88M
CNY-88M
Q2
FY2022 Q4CNY-314.8M
CNY-314.8M
Q4
FY2023 Q2CNY-16.6M
CNY-16.6M
Q2
FY2023 Q4CNY-144.7M
CNY-144.7M
Q4
FY2024 Q2CNY-130.3M
CNY-130.3M
Q2
FY2024 Q4CNY-300.9M
CNY-300.9M
Q4
FY2025 Q2CNY-88M
CNY-88M
Q2
Actual
+CNY42.4M (+32.5%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019BEAT
Actual:CNY173.4M
Est:CNY162.6M
FY2019BEAT
CNY173.4M
FY2020MISS
Actual:CNY35M
Est:CNY186.8M
FY2020MISS
CNY35M
FY2021BEAT
Actual:CNY76.9M
Est:CNY76.4M
FY2021BEAT
CNY76.9M
FY2022MISS
Actual:CNY54.1M
Est:CNY136.4M
FY2022MISS
CNY54.1M
FY2023BEAT
Actual:CNY56.6M
Est:CNY54.5M
FY2023BEAT
CNY56.6M
FY2024MISS
Actual:CNY1.3M
Est:CNY18.7M
FY2024MISS
CNY1.3M

Analyst Estimates